CA2823876A1 - Viral diagnostics - Google Patents

Viral diagnostics Download PDF

Info

Publication number
CA2823876A1
CA2823876A1 CA 2823876 CA2823876A CA2823876A1 CA 2823876 A1 CA2823876 A1 CA 2823876A1 CA 2823876 CA2823876 CA 2823876 CA 2823876 A CA2823876 A CA 2823876A CA 2823876 A1 CA2823876 A1 CA 2823876A1
Authority
CA
Canada
Prior art keywords
seq
lcmv
antibody
fragment
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2823876
Other languages
English (en)
French (fr)
Inventor
Jana TOMASKOVA
Juraj KOPACEK
Jaromir Pastorek
Silvia Pastorekova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOSCIENCE SLOVAKIA
Original Assignee
BIOSCIENCE SLOVAKIA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOSCIENCE SLOVAKIA filed Critical BIOSCIENCE SLOVAKIA
Publication of CA2823876A1 publication Critical patent/CA2823876A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA 2823876 2011-01-07 2012-01-06 Viral diagnostics Abandoned CA2823876A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161430822P 2011-01-07 2011-01-07
US61/430,822 2011-01-07
PCT/IB2012/000293 WO2012093340A2 (en) 2011-01-07 2012-01-06 Viral diagnostics

Publications (1)

Publication Number Publication Date
CA2823876A1 true CA2823876A1 (en) 2012-07-12

Family

ID=45878971

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2823876 Abandoned CA2823876A1 (en) 2011-01-07 2012-01-06 Viral diagnostics

Country Status (7)

Country Link
US (1) US8883429B2 (https=)
EP (2) EP2664680A1 (https=)
JP (1) JP2014502848A (https=)
CN (1) CN103597098A (https=)
AU (1) AU2012204757A1 (https=)
CA (1) CA2823876A1 (https=)
WO (1) WO2012093340A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2604695B1 (en) 2007-12-27 2022-11-16 Universität Zürich Replication-defective arenavirus vectors
US9849192B2 (en) 2009-11-18 2017-12-26 Rutgers, The State University Of New Jersey Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
CA2818237C (en) 2009-11-18 2021-05-18 University Of Medicine And Dentistry Of New Jersey Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
CA2887037A1 (en) * 2012-10-02 2014-04-10 Rutgers, The State University Of New Jersey Specific delivery of toxins conjugated with antibodies to activated matriptase
EP2968506B1 (en) 2013-03-15 2019-07-31 Université de Genève Anti-mycobacterial vaccines
CN115058452A (zh) 2013-12-03 2022-09-16 霍欧奇帕生物科技有限公司 Cmv疫苗
US10342861B2 (en) * 2014-05-27 2019-07-09 University Of Rochester Arenavirus vaccine
JP7145374B2 (ja) 2016-03-18 2022-10-03 ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー インビボでの切断可能連結部分によって抗マトリプターゼ抗体にコンジュゲートされた化学療法剤を用いる腫瘍細胞の標的化
DE102018215551A1 (de) * 2018-09-12 2020-03-12 Virolutions Biotech Gmbh Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten
KR102446014B1 (ko) * 2022-04-19 2022-09-23 주식회사 웰에이블 저시력자용 진단키트 전용 커버
CN119080935B (zh) * 2024-10-11 2026-04-14 上海市同仁医院 一种抗人SMIM45-107aa单克隆抗体及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations

Also Published As

Publication number Publication date
US8883429B2 (en) 2014-11-11
EP2661509A2 (en) 2013-11-13
EP2664680A1 (en) 2013-11-20
AU2012204757A1 (en) 2013-05-02
JP2014502848A (ja) 2014-02-06
WO2012093340A2 (en) 2012-07-12
CN103597098A (zh) 2014-02-19
WO2012093340A3 (en) 2012-12-13
US20120237922A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
US8883429B2 (en) Viral diagnostics
CA3109607C (en) Methods and reagents for diagnosis of sars-cov-2 infection
US11054429B1 (en) SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein binding
KR101785290B1 (ko) 중증 열성 혈소판 감소 증후군 바이러스 감염 진단용 단클론항체, 이를 생산하는 하이브리도마 및 이 단클론항체를 사용하는 중증 열성 혈소판 감소 증후군 바이러스 감염 진단방법
JP7529639B2 (ja) 診断アッセイに使用するためのタンパク質抗原としてのｒｅｐタンパク質
WO2023088444A1 (zh) 一种抗hiv-1 p24的抗体及其制备方法和用途
JPWO2007043582A1 (ja) Ｓａｒｓウイルスヌクレオカプシドタンパク質を測定するための測定方法、測定用試薬キット、試験具、ｓａｒｓウイルスヌクレオカプシドタンパク質に対するモノクローナル抗体及び前記モノクローナル抗体を産生するハイブリドーマ
CN108474017B (zh) 用于检测呼吸道合胞病毒抗原p的单克隆抗体
WO2023088443A1 (zh) 一种抗人IgM抗体及其制备方法和用途
Zhang et al. Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection
WO2013043125A1 (en) Enterovirus 71 specific antibodies and uses thereof
CA3125208A1 (en) Monoclonal antibody or antigen binding fragment thereof that binds to the l protein of the human parainfluenza virus (piv); method and kit for detecting piv
US20220026428A1 (en) Detection of antibodies to sarsr-cov
MacDonald et al. Molecular interactions and trafficking of influenza A virus polymerase proteins analyzed by specific monoclonal antibodies
Kim et al. Development and clinical evaluation of a rapid diagnostic kit for feline leukemia virus infection
Bai et al. Characterization of monoclonal antibodies against duck Tembusu virus E protein: an antigen-capture ELISA for the detection of Tembusu virus infection
Wang et al. Sensitive detection of HEV antibodies using a blocking ELISA based on ORF2-specific monoclonal antibodies
CA3039138C (en) Rep protein as protein antigen for use in diagnostic assays
HK40016702A (en) Rep protein as protein antigen for use in diagnostic assays
JP2010507780A (ja) Ｂ型インフルエンザウイルスの検出

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20170106